OSTX · OS Therapies Inc
$1.76
+0.05 (+2.92%)
At close · Sep 3
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These factors raise substantial doubt about the Company's ability to continue as a going concern within one year after the date that the unaudited consolidated financial statements are issued.”View the 10-Q filed Aug 14, 2026
Market Cap
$76.57M
Shares
46.13M
Press releases and events scraped from the company's investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Upcoming events
| Date | Event | Type |
|---|---|---|
| 2026-09-09 14:00 UTC | 2026 Annual Meeting of Stockholders | Shareholder meeting |
Past events
| Date | Event | Type |
|---|---|---|
| 2026-04-30 | OST-HER2 Pharmacodynamic Response Biomarker Conference Call | Conference |
Source: https://ir.ostherapies.com/
Key facts
CIK
1795091
CUSIP
68764Y207
13F (30d)
27 filings
27 filers
Visit website
Investor relations